Pharyngitis screening: Difference between revisions

Jump to navigation Jump to search
 
Line 6: Line 6:


==Screening==
==Screening==
Screening for etiologic agents of pharyngitis should only be done in symptomatic patients especially population at risk. Anyone during the winter months is at risk of pharyngitis, especially those aged 5 to 15 years. Screening can be performed using [[rapid antigen detection test]] (RADT) or throat culture.<ref name="pmid19246689">Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST et al. (2009) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19246689 Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.] ''Circulation'' 119 (11):1541-51. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.191959 DOI:10.1161/CIRCULATIONAHA.109.191959] PMID: [https://pubmed.gov/19246689 19246689]</ref>
[[Screening]] for [[etiologic]] agents of [[pharyngitis]] should only be done in [[symptomatic]] patients especially populations at risk. Anyone during the winter months is at risk of pharyngitis, especially those aged 5 to 15 years. Screening can be performed using [[rapid antigen detection test]] (RADT) or throat [[culture]]<ref name="pmid19246689">Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST et al. (2009) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19246689 Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.] ''Circulation'' 119 (11):1541-51. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.191959 DOI:10.1161/CIRCULATIONAHA.109.191959] PMID: [https://pubmed.gov/19246689 19246689]</ref>


Screening of asymptomatic carriers can be considered in the following cases:
Screening of asymptomatic carriers can be considered in the following cases:
* Recurrent [[group A streptococcal]] pharyngitis among family members
* Recurrent [[group A streptococcal]] pharyngitis among family members
* During an outbreak of [[rheumatic fever]]
* During an [[outbreak]] of [[rheumatic fever]]
* In patients with personal history of [[acute rheumatic fever]] or [[rheumatic heart disease]]
* In patients with a personal history of [[acute rheumatic fever]] or [[rheumatic heart disease]]


==References==
==References==

Latest revision as of 19:28, 7 December 2020

Pharyngitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pharyngitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pharyngitis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pharyngitis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pharyngitis screening

CDC on Pharyngitis screening

Pharyngitis screening in the news

Blogs on Pharyngitis screening

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pharyngitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]

Overview

Routine screening for pharyngitis is not recommended. Testing for etiologic agents of pharyngitis should only be done in symptomatic patients.

Screening

Screening for etiologic agents of pharyngitis should only be done in symptomatic patients especially populations at risk. Anyone during the winter months is at risk of pharyngitis, especially those aged 5 to 15 years. Screening can be performed using rapid antigen detection test (RADT) or throat culture[1]

Screening of asymptomatic carriers can be considered in the following cases:

References


Template:WH Template:WS